Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 159.74m |
Free float | 157.04m |
P/E (TTM) | -- |
Market cap | 763.55m USD |
EPS (TTM) | -0.016 USD |
Data delayed at least 15 minutes.
More ▼
Press releases
- Ironwood Pharmaceuticals Reports Third Quarter 2024 Results
- Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024
- Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call
- Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference